Form 4: Oscar Health Director Sells Shares Under 10b5-1 Plan

Oscar Health Director Mario Schlosser executed a Rule 10b5-1 trading plan, resulting in the sale of a significant number of Class A common stock shares.

Summary

• Mario Schlosser, a Director at Oscar Health, Inc. (OSCR), has reported transactions involving Class A common stock.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 24, 2026.
• Schlosser acquired 47,500 shares of Class A common stock and subsequently disposed of 4,390, 13,672, and 30,228 shares at weighted average prices of $29.50, $30.80, and $31.65, respectively.
• Following these sales, Schlosser beneficially owns 43,900 shares indirectly through the Pizzo-Schlosser Family Dynasty Trust.
• Additionally, Class B common stock, convertible into Class A common stock, is held indirectly through various trusts, with a significant portion directly owned by Schlosser.
• The filing also notes shares to be issued upon the vesting of restricted stock units.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the director selling shares, even though it was executed under a pre-planned 10b5-1 trading plan. The sale itself, regardless of the plan, represents a reduction in insider ownership.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and planned approach to stock sales, which can mitigate insider trading concerns.
• The Class B common stock is convertible into Class A common stock, offering flexibility and potential future value realization.
• A substantial number of Class A shares (480,866) remain directly beneficially owned by Schlosser, indicating continued significant investment in the company.

Negatives

• A total of 48,290 shares of Class A common stock were sold in multiple transactions at prices ranging from $29.05 to $32.02.
• The sales occurred under a plan, suggesting a predetermined strategy for divestment of shares.

Risks

• The sale of a significant number of shares by a director could be interpreted negatively by the market, potentially impacting share price.
• The conversion of Class B common stock into Class A common stock is subject to certain exceptions and mandatory conversion events, introducing potential complexities.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions.

Management Comments

• Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.
• The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by a director is common practice to diversify holdings or manage personal finances without the appearance of trading on material non-public information. The healthcare technology sector, where Oscar Health operates, often sees such transactions as executives manage their compensation and investment portfolios.

Stakeholder Impact

• Shareholders: May perceive the director's sale as a negative signal, potentially leading to short-term price pressure, despite the 10b5-1 plan.
• Management: The structured sale under a plan aims to avoid negative perceptions of insider trading, maintaining corporate governance standards.
• Creditors: No direct impact is indicated by this filing.

Next Steps

• The reporting person may continue to execute transactions under the Rule 10b5-1 trading plan.
• The company may receive requests for detailed transaction information from security holders or the SEC staff.

Key Dates

Recommendation

The filing reports routine insider stock sales under a Rule 10b5-1 plan. While insider selling can be a negative signal, the structured nature of the sale mitigates concerns about trading on non-public information. The director retains significant beneficial ownership. Therefore, a 'hold' recommendation is appropriate, pending further fundamental analysis of Oscar Health's business performance and outlook.

Keywords

Oscar Health, OSCR, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Director Transactions, Beneficial Ownership, Class A Common Stock, Class B Common Stock, Pizzo-Schlosser Family Dynasty Trust